Načítá se...
Vitamin D Deficiency Increases Severity of Paclitaxel-Induced Peripheral Neuropathy
PURPOSE: Approximately 25% of patients receiving weekly paclitaxel for breast cancer require treatment disruptions to avoid severe, irreversible peripheral neuropathy (PN). Vitamin insufficiencies are PN risk factors in many diseases, but their relevance to chemotherapy-induced PN is unknown. METHOD...
Uloženo v:
| Vydáno v: | Breast Cancer Res Treat |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7945004/ https://ncbi.nlm.nih.gov/pubmed/32166478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05584-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|